Pentixapharm Holding Ag (PTP.D.IX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 118 | 24 | 31 | 59 |
| Cost of Goods | 3,718 | -4,696 | -3,940 | -2,540 |
| Gross Profit | -3,600 | 4,720 | 3,971 | 2,599 |
| Operating Expenses | 13,981 | 10,881 | 6,147 | 4,241 |
| Operating Income | -17,581 | -6,161 | -2,176 | -1,642 |
| Interest Expense | 53 | 183 | 0 | 1 |
| Other Income | 1,084 | 130 | 1,397 | -87 |
| Pre-tax Income | -16,550 | -6,214 | -779 | -1,730 |
| Income Tax | -3,707 | 1,425 | 1,182 | 762 |
| Net Income Continuous | -12,843 | -7,639 | -1,961 | -2,492 |
| Net Income | $-12,843 | $-7,639 | $-1,961 | $-2,492 |
| EPS Basic Total Ops | -0.52 | -0.31 | -0.08 | -0.10 |
| EPS Basic Continuous Ops | -0.52 | -0.31 | -0.08 | -0.10 |
| EPS Diluted Total Ops | -0.52 | -0.31 | -0.08 | -0.10 |
| EPS Diluted Continuous Ops | -0.52 | -0.31 | -0.08 | -0.10 |
| EBITDA(a) | $2,547 | $-5,884 | $-665 | $-1,623 |